China CMDE released its annual report of 2023. Some of the important data is as follows:
1.Submissions Overview
- Submissions Accepted: 24,935, which includes:
2.Emergency review
3.Time Spent for Review
Application Type | Product Classification | Average Review Time | Average expert consultation time | Average Supplement time | Total Time |
Initial Registration | Class II | 72 | 0 | 259 | 332 |
Class III | 98 | 1 | 173 | 274 | |
Class II+III | 95 | 1 | 182 | 280 | |
Registration Modification | Class II | 43 | 0 | 68 | 111 |
Class III | 66 | 0 | 68 | 136 | |
Class II+III | 62 | 0 | 68 | 131 | |
Registration Renew | Class II | 20 | 0 | 2 | 22 |
Class III | 23 | 0 | 6 | 29 | |
Class II+III | 22 | 0 | 5 | 27 |
4.Communication with the Applicants
Total: 28534, which includes
5.RFE, Advisory Meeting and Audit Overview
RFEs and Responses to RFEs | RFE released: 6,399 |
RFE Response Accepted: 5,867 | |
Advisory Meetings | Meeting initiated: 102 |
Meeting conducted: 103 | |
PAI (Preapproval QMS Inspection) | PAI Initiated: 3,439 |
PAI Completed: 3,170 |
6.Innovation review, priority review
Special review of innovative medical devices | Submission: 466, 35.9% ↑(YoY). |
Organize expert review meetings 362 | |
Complete review 446 | |
Priority approval of medical device review | Submission: 31, same as last year |
Advisory Meeting Conducted: 5 | |
Review Completes: 30 |